mitothiorole (Celestial Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namemitothiorole (Celestial Pharmaceuticals)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet-derived growth factor receptor inhibitorsVascular endothelial growth factor receptor antagonists
TargetsPlatelet-derived growth factor receptorVascular endothelial growth factor receptor
Therapy Area/IndicationsLeukopeniaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShenzhen Celestial Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenzhen Celestial Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsLeukopeniaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A